Ciprofloxacin is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Uncomplicated UTI (ciprofloxacin XR and ciprofloxacin), complicated UTI (ciprofloxacin).
  • Post-exposure prophylaxis for inhalation anthrax. CDC recommends as first line agent + 1-2 additional agent(s) with in vitro activity (for inhalation anthrax, see "biodefense-anthrax" module).
  • Complicated intra-abdominal infections (in combination with metronidazole)
  • Infectious diarrhea
  • Endocervical and urethral infections caused N. gonorrhoeae (high resistance rates reported in Hawaii and California).
  • Empiric therapy for neutropenic fever (in combination with piperacillin); typhoid fever
  • Nosocomial pneumonia
  • Prostatitis
  • Acute sinusitis
  • Skin and soft tissue infections; bone and joint infections 11) bacterial conjunctivitis (ophthalmic ointment) 12) bacterial conjuctivitis and corneal ulcers (ophthalmic solution) 13) Acute otitis externa (otic suspension)

NON-FDA APPROVED USES

  • Tuberculosis, MAC and other atypical mycobacterial infections (2nd or 3rd line)

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: December 22, 2011